Xenon Pharmaceuticals Inc. (XENE)

Recent filings

Xenon Pharmaceuticals: Xenon Presents Xen901 Phase 1 Clinical Update And Supporting Pre-Clinical Data At 14Th Eilat Conference - May 15, 2018

Xenon Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - May 8, 2018

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 5. Net income ... - May 8, 2018

Mark N. Lampert just provided an update on share ownership of Xenon Pharmaceuticals Inc. - March 29, 2018

Major owner of Xenon Pharmaceuticals Inc. just disposed of 2,437,000 shares - March 29, 2018

Xenon Pharmaceuticals Confirms Closing Of Transaction With Teva And Announces Preferred Share Exchange Agreement With Bvf Partners L.P - March 28, 2018

Xenon Pharmaceuticals Inc.'s Chief Medical Officer was just granted 50,000 options - March 20, 2018

Initial statement of beneficial ownership of securities - March 20, 2018

Xenon Pharmaceuticals Inc. director just picked up 3,086 shares - March 16, 2018

Xenon Pharmaceuticals: American Stock Transfer & Trust Company, Llc Charlotte, North Carolina - March 15, 2018

Xenon Pharmaceuticals Inc.'s CEO just picked up 10,288 shares - March 14, 2018

SVP of Xenon Pharmaceuticals Inc. was just granted 45,000 options - March 13, 2018

Xenon Pharmaceuticals Inc.'s PRESIDENT & CFO was just granted 105,000 options - March 13, 2018

Xenon Pharmaceuticals Inc.'s CEO was just granted 140,000 options - March 13, 2018

VP of Xenon Pharmaceuticals Inc. was just granted 40,000 options - March 13, 2018

Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals As Chief Medical Officer - March 13, 2018

Xenon Pharmaceuticals Inc.'s EVP Bus. & Corp. Development was just granted 55,000 options - March 13, 2018

Xenon Pharmaceuticals Inc. Just Filed Its Annual Report: 5. Net income ... - March 7, 2018

Xenon Pharmaceuticals Reports 2017 Financial Results And Provides Corporate Update - March 7, 2018

Securities to be offered to employees in employee benefit plans - March 7, 2018

Entry into a Material Definitive - March 7, 2018

Xenon Pharmaceuticals Inc. director just disposed of 8,400 shares - March 1, 2018

VP of Xenon Pharmaceuticals Inc. just picked up 4,079 shares - Feb. 14, 2018

Mark N. Lampert just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 14, 2018

OrbiMed Advisors LLC just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 13, 2018

Confidential treatment order - Feb. 1, 2018

Xenon Pharmaceuticals Outlines Key Milestones For 2018 - Jan. 8, 2018

Entry into a Material Definitive - Dec. 18, 2017

Xenon Pharmaceuticals Inc. director just picked up 15,000 shares - Nov. 16, 2017

Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Corporate Update - Nov. 7, 2017

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 4. Net income ... - Nov. 7, 2017

Xenon Pharmaceuticals Inc.'s SVP Bus. & Corp. Development was just granted 11,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc.'s CFO & COO was just granted 25,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc.'s President & CEO was just granted 11,000 options - Oct. 24, 2017

SVP of Xenon Pharmaceuticals Inc. was just granted 20,000 options - Oct. 24, 2017

VP of Xenon Pharmaceuticals Inc. was just granted 11,000 options - Oct. 24, 2017

SVP of Xenon Pharmaceuticals Inc. was just granted 11,000 options - Oct. 24, 2017

Xenon Pharmaceuticals Inc. director just picked up 10,000 shares - Sept. 25, 2017

Confidential treatment order - Sept. 18, 2017

Confidential treatment order - Sept. 5, 2017

Head of Xenon Pharmaceuticals Inc. just picked up 1,000 shares - Aug. 21, 2017

Xenon Pharmaceuticals Inc. director just picked up 6,335 shares - Aug. 21, 2017

SVP of Xenon Pharmaceuticals Inc. just picked up 10,000 shares - Aug. 17, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 60,202 shares - Aug. 16, 2017

Xenon Pharmaceuticals Inc. director just picked up 50,000 shares - Aug. 15, 2017

Xenon Pharmaceuticals Inc. director just picked up 7,500 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc.'s CFO & COO just picked up 15,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 15,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 7,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 15,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc.'s President & CEO just picked up 6,000 shares - Aug. 14, 2017

Xenon Pharmaceuticals Inc. director just picked up 5,000 shares - Aug. 10, 2017

Xenon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides Corporate Update - Aug. 3, 2017

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 4. Net income ... - Aug. 3, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 85,461 shares - June 30, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 85,461 shares - June 29, 2017

Xenon Pharmaceuticals: Jerusalem & Burnaby, British Columbia -- June 27, 2017 - June 27, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 20,411 shares - June 23, 2017

Xenon Pharmaceuticals Inc. director just cashed-in 1,028 options - June 20, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 26,408 shares - June 19, 2017

Major owner of Xenon Pharmaceuticals Inc. just picked up 358,698 shares - June 8, 2017

Submission of Matters to a Vote of - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 4,750 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc. director was just granted 3,500 options - June 2, 2017

Xenon Pharmaceuticals Inc.'s SVP Bus. & Corp. Development just picked up 712 shares - May 16, 2017

Xenon Pharmaceuticals Inc. Just Filed Its Quarterly Report: 4. Net income ... - May 9, 2017

Xenon Pharmaceuticals: Results Of Operations And Financial Condition - May 9, 2017

Xenon Pharmaceuticals Inc. releases salary data. CEO sees compensation fall -60% - April 27, 2017

Xenon Pharmaceuticals: Xenon Expands Ion Channel Neurology Pipeline With Acquisition Of New Potassium Channel Modulator - April 26, 2017

Xenon Pharmaceuticals Announces Xen801 Did Not Meet Efficacy Endpoints In Phase 2 - March 24, 2017

Xenon Pharmaceuticals Inc. director just picked up 60,698 shares - March 15, 2017

Departure of Directors or Certain - March 14, 2017

Xenon Pharmaceuticals Inc.'s CFO & COO was just granted 75,000 options - March 14, 2017

SVP of Xenon Pharmaceuticals Inc. was just granted 27,500 options - March 14, 2017

Head of Xenon Pharmaceuticals Inc. was just granted 20,000 options - March 14, 2017

Xenon Pharmaceuticals Inc.'s President & CEO was just granted 140,000 options - March 14, 2017

SVP of Xenon Pharmaceuticals Inc. was just granted 27,500 options - March 14, 2017

Xenon Pharmaceuticals Inc.'s SVP Bus. & Corp. Development was just granted 27,500 options - March 14, 2017

VP of Xenon Pharmaceuticals Inc. was just granted 20,000 options - March 14, 2017

Xenon Pharmaceuticals: American Stock Transfer & Trust Company, Llc Seattle, Washington - March 9, 2017

Xenon Pharmaceuticals Inc. Just Filed Its Annual Report:   (m) Net inc... - March 8, 2017

Securities to be offered to employees in employee benefit plans - March 8, 2017

Xenon Pharmaceuticals: Results Of Operations And Financial Condition - March 8, 2017

Statement of acquisition of beneficial ownership by individuals - Feb. 14, 2017

Arnold L. Oronsky just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 14, 2017

Mark N. Lampert just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 14, 2017

just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 13, 2017

August J. Troendle just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 13, 2017

Samuel D. Isaly just provided an update on share ownership of Xenon Pharmaceuticals Inc. - Feb. 13, 2017

Effective January - Jan. 3, 2017

Xenon Pharmaceuticals Inc. director just disposed of 30,000 shares - Dec. 19, 2016

Xenon Pharmaceuticals Inc. director just picked up 7,201 shares - Dec. 13, 2016

Xenon Pharmaceuticals Inc. director just picked up 7,942 shares - Dec. 8, 2016

Xenon Pharmaceuticals Inc. director just picked up 7,937 shares - Dec. 2, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Capital World Investors 1,429,000 N/A Sept. 30, 2017
2. 1,077,241 N/A Dec. 31, 2015
3. Arnold L. Oronsky 767,187 N/A Dec. 31, 2015
4. Biotechnology Value Fund, L.P. 767,168 N/A March 16, 2016
5. BVF INC/IL 720,830 0.4 March 31, 2018
6. ORBIMED ADVISORS LLC 634,812 N/A Sept. 30, 2017
7. Schonfeld Strategic Advisors LLC 385,000 0.1 Dec. 31, 2017
8. DAFNA Capital Management LLC 377,695 0.7 Sept. 30, 2017
9. ROYAL BANK OF CANADA 367,311 N/A Sept. 30, 2016
10. Invesco Private Capital, Inc. 341,884 0.9 Dec. 31, 2017
11. SABBY MANAGEMENT, LLC 329,400 0.1 Dec. 31, 2017
12. Point72 Asset Management, L.P. 307,079 N/A March 31, 2018
13. Tekla Capital Management LLC 280,000 0.1 March 31, 2018
14. RENAISSANCE TECHNOLOGIES LLC 156,400 N/A Sept. 30, 2017
15. Artal Group S.A. 150,000 N/A Dec. 31, 2017
16. K2 PRINCIPAL FUND, L.P. 101,103 N/A March 31, 2018
17. Knott David M 94,000 0.1 Dec. 31, 2017
18. State of New Jersey Common Pension Fund D 65,000 N/A March 31, 2018
19. SCOTIA CAPITAL INC. 62,918 N/A Dec. 31, 2017
20. CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 55,000 N/A March 31, 2018
21. DRW Securities, LLC 30,000 N/A Dec. 31, 2017
22. KCG Holdings, Inc. 23,367 N/A June 30, 2017
23. STIFEL FINANCIAL CORP 22,200 N/A Dec. 31, 2017
24. NJ State Employees Deferred Compensation Plan 20,000 N/A March 31, 2018
25. Leith Wheeler Investment Counsel Ltd. 16,075 0.1 March 31, 2018
26. RBF Capital, LLC 15,100 N/A March 31, 2018
27. DIMENSIONAL FUND ADVISORS LP 11,120 N/A Dec. 31, 2017
28. OPPENHEIMER FUNDS INC 11,005 N/A March 31, 2018
29. JPMORGAN CHASE & CO 9,226 N/A Sept. 30, 2017
30. DEUTSCHE BANK AG\ 8,719 N/A Dec. 31, 2017

Xenon Pharmaceuticals Inc. (XENE)

140
 


Feedback